Bronfman E.L. Rothschild L.P. decreased its holdings in Becton, Dickinson and Company (NYSE:BDX) by 2.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,083 shares of the medical instruments supplier’s stock after selling 280 shares during the quarter. Bronfman E.L. Rothschild L.P.’s holdings in Becton, Dickinson and were worth $2,564,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Almanack Investment Partners LLC. acquired a new position in shares of Becton, Dickinson and during the first quarter valued at approximately $105,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of Becton, Dickinson and by 55.8% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock valued at $131,000 after acquiring an additional 240 shares during the last quarter. Parkside Financial Bank & Trust raised its holdings in shares of Becton, Dickinson and by 8.1% during the second quarter. Parkside Financial Bank & Trust now owns 684 shares of the medical instruments supplier’s stock valued at $133,000 after acquiring an additional 51 shares during the last quarter. Harfst & Associates Inc. raised its holdings in shares of Becton, Dickinson and by 46.4% during the second quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock valued at $135,000 after acquiring an additional 221 shares during the last quarter. Finally, Financial Architects Inc raised its holdings in shares of Becton, Dickinson and by 8.0% during the second quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock valued at $142,000 after acquiring an additional 54 shares during the last quarter. 87.91% of the stock is owned by institutional investors.

Several research firms recently commented on BDX. BidaskClub raised Becton, Dickinson and from a “hold” rating to a “buy” rating in a report on Monday, August 14th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $210.00 price target on shares of Becton, Dickinson and in a report on Wednesday, October 25th. Zacks Investment Research raised Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $234.00 price target for the company in a report on Tuesday, October 31st. Cowen and Company reaffirmed a “buy” rating and issued a $230.00 price target on shares of Becton, Dickinson and in a report on Monday, August 14th. Finally, Barclays PLC reiterated an “equal weight” rating and issued a $210.00 price objective (up from $205.00) on shares of Becton, Dickinson and in a research report on Thursday, August 10th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $217.08.

In other Becton, Dickinson and news, insider Gary M. Cohen sold 15,512 shares of the firm’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $203.77, for a total value of $3,160,880.24. Following the sale, the insider now directly owns 95,781 shares in the company, valued at $19,517,294.37. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Stephen Sichak sold 11,787 shares of the firm’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $200.46, for a total value of $2,362,822.02. Following the completion of the sale, the insider now owns 14,038 shares in the company, valued at $2,814,057.48. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “Bronfman E.L. Rothschild L.P. Has $2.56 Million Position in Becton, Dickinson and Company (BDX)” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.watchlistnews.com/bronfman-e-l-rothschild-l-p-has-2-56-million-position-in-becton-dickinson-and-company-bdx/1720089.html.

Becton, Dickinson and Company (NYSE BDX) traded up $5.33 on Wednesday, hitting $226.83. The stock had a trading volume of 1,476,500 shares, compared to its average volume of 1,323,648. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $227.50. The stock has a market capitalization of $50,405.64, a price-to-earnings ratio of 23.34, a P/E/G ratio of 1.73 and a beta of 1.04. The company has a debt-to-equity ratio of 1.48, a quick ratio of 5.01 and a current ratio of 5.56.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings data on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.37 by $0.03. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.14 billion. Becton, Dickinson and had a return on equity of 22.51% and a net margin of 8.52%. The company’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period last year, the firm earned $2.12 earnings per share. research analysts expect that Becton, Dickinson and Company will post 10.63 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 8th will be paid a $0.75 dividend. This is a boost from Becton, Dickinson and’s previous quarterly dividend of $0.73. This represents a $3.00 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, December 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is presently 62.80%.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.